Retirement Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-61
| Closed | -$8.83K | – | 883 |
|
|
2023
Q4 | $8.83K | Hold |
61
| – | – | ﹤0.01% | 467 |
|
|
2023
Q3 | $10.4K | Hold |
61
| – | – | ﹤0.01% | 406 |
|
|
2023
Q2 | $13.6K | Hold |
61
| – | – | 0.01% | 373 |
|
|
2023
Q1 | $13K | Hold |
61
| – | – | 0.01% | 367 |
|
|
2022
Q4 | $13K | Hold |
61
| – | – | 0.01% | 331 |
|
|
2022
Q3 | $16K | Buy |
61
+1
| +2% | +$262 | 0.01% | 207 |
|
|
2022
Q2 | $13K | Hold |
60
| – | – | 0.01% | 399 |
|
|
2022
Q1 | $13K | Hold |
60
| – | – | 0.01% | 421 |
|
|
2021
Q4 | $14K | Hold |
60
| – | – | 0.01% | 384 |
|
|
2021
Q3 | $13K | Buy |
60
+51
| +567% | +$9.37K | 0.01% | 365 |
|
|
2021
Q2 | $2K | Hold |
9
| – | – | ﹤0.01% | 587 |
|
|
2021
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 723 |
|
|
2020
Q4 | $1K | Buy |
+9
| New | +$1.16K | ﹤0.01% | 638 |
|
Retirement Group's ALXN Position: Q1 2024 in Review
Retirement Group sold out of Alexion Pharmaceuticals (ALXN) in Q1 2024, closing a stake of 61 shares — an estimated $8.83K sold.
Retirement Group first reported a position in ALXN in Q4 2020 and held it in 13 quarters. The position peaked at $16K in Q3 2022. 0 funds tracked by Wall St. Rank hold ALXN as of Q1 2024.
- Retirement Group reported no remaining Alexion Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
- Retirement Group sold 61 Alexion Pharmaceuticals shares in Q1 2024, an estimated $8.83K.
- Retirement Group first reported a position in Alexion Pharmaceuticals in Q4 2020 and held it in 13 quarters.
- Retirement Group's Alexion Pharmaceuticals position peaked at $16K in Q3 2022.
- 0 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2024.
Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.